Aniling

Aniling possesses GEUS technology, which unifies genetic and epigenetic sequencing and provides an end-to-end solution for accurate treatment decisions in oncology. Based on GEUS, Aniling is developing a suite of products for cancer diagnosis. GEUS-CLL offers precise staging and treatment decision-making. Aniling S.L. provides the GEUS-CLL diagnostic test as a service to other laboratories and hospitals.